Anti-Infective Drugs Advisory Committee
March 24, 2000
Zyox (linezolid) NDA 21-130, NDA 21-131, NDA 21-132
FDA Briefing Packagedoc pdf
The statements contained in this document are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
Pharmacia & Upjohn Company
Appendix A: Preclinical Summary
Appendix B: Study Synopses